Jefferson Health

Physician Profile

Richard Kaiser, MD

Academic Title: Associate Professor

Specialties
Ophthalmology - Retina

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

Philadelphia
840 Walnut Street
Suite 1020
Philadelphia PA 19107
Phone: (800) 331-6634

Medical Services

Board Certifications

  • OPH Retina

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital

Education

  • New York University School of Medicine, Medical School

Internship

  • Hospital of the University of Pennsylvania

Residency

  • Hospital of the University of Pennsylvania

Recent Publications

A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROL PILOT STUDY OF EPLERENONE FOR THE TREATMENT OF CENTRAL SEROUS CHORIORETINOPATHY (ECSELSIOR)

Microbial spectrum and outcomes of endophthalmitis after intravitreal injection versus pars plana vitrectomy

Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials

Reply

Bimanual assisted eyelid retraction technique for intravitreal injections

Updates on the management of AMD and CRVO: An evidence-based approach

Updates on the management of AMD and RVO: An evidence-based approach

Anti-PDGF combination therapy for AMD

Electroretinographic effects of omega-3 fatty acid supplementation on dry age-related macular degeneration

Maximizing patient outcomes in AMD: A review of evolving, evidence-based therapeutic options for clinical practice

Commentary on ACA from the editors of new retina MD: Commentary on ACA from the editors of new retina MD

Orbital hemorrhage after intravitreal injection

The sunshine act's intimidation factor: Will the noble objectives of this law set up a roadblock to innovation?

Bevacizumab for neovascular age-related macular degeneration using a treat-and-extend regimen: Clinical and economic impact

Ranibizumab for eyes previously treated with pegaptanib or bevacizumab without clinical response

Association between high-risk disease loci and response to anti-vascular endothelial growth factor treatment for wet age-related macular degeneration

23-gauge transconjunctival pars plana vitrectomy for Removal of retained lens fragments

Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents

Endophthalmitis in microincision vitrectomy: Outcomes of gas-filled eyes

A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration: Clinical and economic impact